Low-dose cyclosporin therapy for recombinant erythropoietin-induced pure red-cell aplasia

Nephrology Dialysis Transplantation

Volumn 19, Issue 2, 2004, Pages 479-481

  Duffield, Jeremy S ^a   Mann, Susan ^a   Horn, Lichel ^a   Winney, Robin J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Anaemia; Cyclosporin; Erythropoietin; Pure red cell aplasia; Renal impairment

Indexed keywords

CLARITHROMYCIN; CLINDAMYCIN; CYCLOSPORIN; IRON; LISINOPRIL; METOPROLOL; NEUTRALIZING ANTIBODY; RECOMBINANT ERYTHROPOIETIN; THROMBOCYTE CONCENTRATE;

ADULT; AMPUTATION STUMP; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOW DRUG DOSE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REMISSION; SURGICAL INFECTION;

CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RED-CELL APLASIA, PURE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 1042280352     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg535     Document Type: Article

References (13)

1. Casadevall N, Nataf J, Viron B et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002; 346: 469-475
2. Peces R, de la Torre M, Alcazar R, Urra JM. Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia. N Engl J Med 1996; 335: 523-524
3. Prabhakar SS, Muhlfelder T. Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 1997; 47: 331-335
4. Jannot-Lamotte MF, Raccah D. Management of diabetes during corticosteroid therapy. Presse Med 2000; 29: 263-266
5. Kim YS, Kim MS, Kim SI et al. Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants. Transpl Int 1997; 10: 197-201
6. Means RT, Jr, Dessypris EN, Krantz SB. Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response. Br J Haematol 1991; 78: 114-119
7. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996; 334: 630-633
8. Peschle C, Marmont AM, Marone G, Genovese A, Sasso GF, Condorelli M. Pure red cell aplasia: studies on an IgG serum inhibitor neutralizing erythropoietin. Br J Haematol 1975; 30: 411-417
9. Garcia JE, Senent C, Pascual C et al. Anaphylactic reaction to recombinant human erythropoietin. Nephron 1993; 65: 636-637
10. Dessypris EN. The biology of pure red cell aplasia. Semin Hematol 1991; 28: 275-284.
11. Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996; 87: 3000-3006
12. Marmont A, Peschle C, Sanguineti M, Condorelli M. Pure red cell aplasia (PRCA): response of three patients to cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis. Blood 1975; 45: 247-261
13. Marmont AM. Therapy of pure red cell aplasia. Semin Hematol 1991; 28: 285-297